DK43991A - Allele varianter af plasmodium falciparum merozoitoverfladeantigen - Google Patents

Allele varianter af plasmodium falciparum merozoitoverfladeantigen Download PDF

Info

Publication number
DK43991A
DK43991A DK043991A DK43991A DK43991A DK 43991 A DK43991 A DK 43991A DK 043991 A DK043991 A DK 043991A DK 43991 A DK43991 A DK 43991A DK 43991 A DK43991 A DK 43991A
Authority
DK
Denmark
Prior art keywords
terminal
surface antigen
plasmodium falciparum
sequences
plasts
Prior art date
Application number
DK043991A
Other languages
English (en)
Other versions
DK43991D0 (da
Inventor
Jason Arthur Smythe
Robin Fredric Anders
David James Kemp
Ross Leon Coppel
Allan James Saul
Graham Lloyd Jones
David Owen Irving
Sandra Leigh Dyer
David Wai Wing Chee
Neil Howard Goss
Original Assignee
Saramane Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saramane Pty Ltd filed Critical Saramane Pty Ltd
Publication of DK43991D0 publication Critical patent/DK43991D0/da
Publication of DK43991A publication Critical patent/DK43991A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1085Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088Glutathione transferase (2.5.1.18)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DK043991A 1988-09-12 1991-03-12 Allele varianter af plasmodium falciparum merozoitoverfladeantigen DK43991A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPJ038288 1988-09-12
AUPJ596289 1989-08-24
PCT/AU1989/000388 WO1990002752A1 (en) 1988-09-12 1989-09-12 Allelic variants of plasmodium falciparum merozoite surface antigen

Publications (2)

Publication Number Publication Date
DK43991D0 DK43991D0 (da) 1991-03-12
DK43991A true DK43991A (da) 1991-05-08

Family

ID=25643542

Family Applications (1)

Application Number Title Priority Date Filing Date
DK043991A DK43991A (da) 1988-09-12 1991-03-12 Allele varianter af plasmodium falciparum merozoitoverfladeantigen

Country Status (9)

Country Link
EP (1) EP0433378B1 (da)
JP (1) JPH04500668A (da)
KR (1) KR900701831A (da)
AT (1) ATE129504T1 (da)
DE (1) DE68924649D1 (da)
DK (1) DK43991A (da)
IL (1) IL91609A0 (da)
WO (1) WO1990002752A1 (da)
ZA (1) ZA896942B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0434751A1 (en) * 1988-09-16 1991-07-03 Statens Seruminstitut A malaria antigen
FR2697022B1 (fr) * 1992-10-19 1994-12-16 Pasteur Institut Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
US20030161840A1 (en) 1992-10-19 2003-08-28 Institut Pasteur Plasmodium falciparum antigens inducing protective antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
JPS61107292A (ja) * 1984-10-30 1986-05-26 株式会社東芝 出力装置
AU595056B2 (en) * 1986-07-17 1990-03-22 Program For Appropriate Technology In Health (Path) Merozoite surface antigen of plasmodium falciparum

Also Published As

Publication number Publication date
ZA896942B (en) 1990-08-29
DK43991D0 (da) 1991-03-12
EP0433378A1 (en) 1991-06-26
DE68924649D1 (de) 1995-11-30
IL91609A0 (en) 1990-04-29
JPH04500668A (ja) 1992-02-06
EP0433378A4 (en) 1991-11-06
EP0433378B1 (en) 1995-10-25
KR900701831A (ko) 1990-12-04
WO1990002752A1 (en) 1990-03-22
ATE129504T1 (de) 1995-11-15

Similar Documents

Publication Publication Date Title
DK0423302T3 (da) Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner
PT100781A (pt) Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas
DE68924162D1 (de) Stressproteine und verwendungen dafür.
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
AR006999A1 (es) Una composición inmunogénica, terapéutica o profiláctica , que comprende un polipéptido omp106 aislado, un anticuerpo aislado que se liga a dicho polipéptido y una vacuna que lo comprende.
DE69922958D1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
ATE171710T1 (de) Hcv peptidantigene und verfahren zur bestimmung von hcv
DK0439056T3 (da) Coccidiose-vacciner
FI940036A (fi) Nukleotidisekvenssejä ja sykloheksimidiresistenssejä proteiineja
DK43991A (da) Allele varianter af plasmodium falciparum merozoitoverfladeantigen
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
DE3776034D1 (de) Vakzine.
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
AU660437B2 (en) Protective plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens HRPII and SERP, the preparation and use thereof
ATE312923T1 (de) Moraxella catarrhalis basb034 polypeptide und verwendungen davon
ATE143373T1 (de) Proteine, vakzine und nucleinsäuren
WO1994025594A3 (en) Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii